oxcarbazepine
Generic: oxcarbazepine
Labeler: sun pharmaceutical industries, inc.Drug Facts
Product Profile
Brand Name
oxcarbazepine
Generic Name
oxcarbazepine
Labeler
sun pharmaceutical industries, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
oxcarbazepine 60 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51672-1393
Product ID
51672-1393_440646d8-f538-5968-e063-6394a90ab7cd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078734
Listing Expiration
2026-12-31
Marketing Start
2025-08-06
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516721393
Hyphenated Format
51672-1393
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxcarbazepine (source: ndc)
Generic Name
oxcarbazepine (source: ndc)
Application Number
ANDA078734 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/mL
Packaging
- 1 BOTTLE, GLASS in 1 CARTON (51672-1393-1) / 250 mL in 1 BOTTLE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "440646d8-f538-5968-e063-6394a90ab7cd", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["283536"], "spl_set_id": ["9d5ba8a3-d1ea-4d5b-aafd-3a7ba2d4746c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (51672-1393-1) / 250 mL in 1 BOTTLE, GLASS", "package_ndc": "51672-1393-1", "marketing_start_date": "20250806"}], "brand_name": "OXCARBAZEPINE", "product_id": "51672-1393_440646d8-f538-5968-e063-6394a90ab7cd", "dosage_form": "SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-1393", "generic_name": "OXCARBAZEPINE", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "60 mg/mL"}], "application_number": "ANDA078734", "marketing_category": "ANDA", "marketing_start_date": "20250806", "listing_expiration_date": "20261231"}